“A Case Series of 13 Patients With COVID-19 Associated Respiratory Symptoms Treated With Nebulized OTR4120 (Cacipliq20®)”. 2022. Archives of Clinical and Medical Case Reports 6 (4): 604-10. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22658.